Indeed, the treatment with TAK242, a specific inhibitor of TLR4 with anti-inflammatory effect, restored the mitochondrial morphology and partially the architecture of the mitochondrial cristae in T2DM myotubes. The gene discussed is TLR4; the disease is type 2 diabetes mellitus.